Papers
2
Total Citations
6
H-Index
2
About
Shun Umeda’s research focuses on the intersection of urologic oncology and bone health, with a particular emphasis on the skeletal consequences of prostate cancer treatments. His most impactful work, published in 2024, employs quantitative computed tomography to precisely measure lumbar spine bone loss in a propensity-matched cohort of prostate cancer patients undergoing androgen deprivation therapy (ADT). This study, which has already garnered 4 citations, addresses the critical clinical issue of fragility fracture risk, providing objective, volumetric data that surpasses traditional DXA scans in accuracy. By demonstrating the degree and pattern of trabecular bone deterioration, Umeda’s findings offer actionable insights for preemptive bone-protective strategies in men on ADT. He has also contributed to the diagnostic literature with a 2021 case report on perirenal non-specific lymphadenitis mimicking a solitary renal mass, highlighting the challenges of small renal mass diagnosis and the nuanced role of renal tumor biopsy. Umeda’s work is notable for its methodological rigor—using advanced imaging to solve a common, yet underappreciated, treatment complication—and for bridging the gap between urologic practice and musculoskeletal medicine. His research is essential reading for clinicians managing long-term survivorship in prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2